Clinical Trials
- Heart/Cardiovascular
SCOPE-CLI: Shifting Care and Outcomes for Patients with Endangered limbs Critical Limb Ischemia
- Ages19 years and older
- GenderBoth
- Heart/Cardiovascular
Double blind randomized autologous stem cell trial treatment for peripheral arterial disease (PAD) with critical limb threatening ischemia
- Ages18 years and older
- GenderBoth
- Heart/Cardiovascular
Percutaneous Deep Vein Arterialization for the Treatment of Late-Stage Chronic Limb-Threatening Ischemia: The PROMISE III Trial
- Ages18 years - 95 years
- GenderBoth
- Blood Disorders, Infectious Disease
Crystalloid Liberal or Vasopressors Early Resuscitation in Sepsis (CLOVERS)
- Ages18 years and older
- GenderBoth